The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
The Titans go into the NFL draft flexible at No. 7 with lots of needs to fill
Politics updates: Kāinga Ora crackdown, changes to plug
Immigration declines nearly half of study visa applications from India so far this year
Wellington's Reading Cinemas deal debate to go public
Hanna and Haley Cavinder say they're returning for last season at Miami
Government rejects Auckland Mayor Wayne Brown's demands over rates, GST
Chocolate: Cocoa price hits record high as El Niño hurts crops
With House speaker at his side, Trump suggests Ukraine aid should be loan
Armenian victims group ask International Criminal Court to investigate genocide claim
EDITORIAL: Here we go again; another pledge by LDP to reform itself
Protesting Spanish professor 'warned university' over Confucius Institutes — Radio Free Asia
With House speaker at his side, Trump suggests Ukraine aid should be loan